Sumatriptan Dosing for Acute Migraine in Adults
For acute migraine treatment in adults, use sumatriptan 50-100 mg orally (maximum 200 mg/24 hours), 6 mg subcutaneously (may repeat once after 1 hour, maximum 12 mg/24 hours), or 20 mg intranasal spray (maximum 40 mg/24 hours), with subcutaneous administration providing the fastest and most effective relief.
Oral Sumatriptan Dosing
The FDA-approved oral doses are 25 mg, 50 mg, or 100 mg 1. Evidence demonstrates that:
- 50 mg and 100 mg provide greater efficacy than 25 mg
- 100 mg does NOT provide significantly greater effect than 50 mg but carries higher adverse event risk 2, 1
- Start with 50 mg for most patients as the optimal balance of efficacy and tolerability
- If headache returns or partial response occurs, may repeat dose after 2 hours
- Maximum daily dose: 200 mg in 24 hours 2, 1
Hepatic Impairment Consideration
In patients with mild-to-moderate hepatic impairment, do not exceed 50 mg single dose due to unpredictable elevations in bioavailability 2, 1.
Subcutaneous Sumatriptan Dosing
The recommended dose is 6 mg subcutaneously 3, 4. This route provides:
- Fastest onset of action among all formulations
- Highest efficacy: NNT of 2.0 for pain-free at 1 hour (compared to 3.0 for oral at 2 hours) 5
- 73% headache relief rate at 1 hour with 6 mg dose 3
- The 8 mg dose showed similar efficacy to 6 mg but with more adverse events 3
- May repeat once after 1 hour if needed
- Maximum: 12 mg in 24 hours (two 6 mg doses)
Use subcutaneous route for severe attacks or when nausea/vomiting precludes oral administration 6.
Intranasal Sumatriptan Dosing
The recommended dose is 20 mg (single spray in one nostril) 7. Key characteristics:
- 20 mg significantly superior to 5 mg and 10 mg doses at 2 hours (64% vs 46-49% headache relief) 7
- 42% pain-free rate at 2 hours with 20 mg dose 7
- Efficacy comparable to oral sumatriptan but with faster onset than oral 5
- May repeat after 2 hours if needed
- Maximum: 40 mg in 24 hours
Route Selection Algorithm
Subcutaneous (6 mg): Use for severe attacks, rapid relief needed, or presence of severe nausea/vomiting 6, 8
Oral (50-100 mg): First-line for moderate-to-severe attacks without severe nausea 6
Intranasal (20 mg): Alternative when oral not tolerated or faster onset desired than oral 7
Critical Timing and Combination Guidance
- Treat early during mild pain phase for better outcomes 9
- Combine with NSAID or acetaminophen for enhanced efficacy per 2025 ACP guidelines 6
- After initial subcutaneous dose, may use oral sumatriptan (up to 100 mg/day) with at least 2-hour interval 2, 1
Medication Overuse Headache Warning
Limit sumatriptan use to ≤10 days per month to prevent medication overuse headache 6. This threshold is lower than NSAIDs (≤15 days/month).
Contraindications
Do NOT use with MAO-A inhibitors - causes unpredictable elevations in sumatriptan bioavailability 2.
Comparative Efficacy Summary
Based on systematic review data 5:
- Subcutaneous 6 mg: NNT 2.0 at 1 hour (most effective, fastest)
- Oral 100 mg: NNT 4.7 at 2 hours
- Intranasal 20 mg: NNT 3.1 at 2 hours
Subcutaneous causes more adverse events (NNT for harm 3.0) compared to oral (NNT 8.3), but events are typically transient and mild 5, 4.